ReviewImmunity, inflammation and disease2025
Research Progress of Plasma Cell Mastitis.
Review in Immunity, inflammation and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Accessory breast plasma cell mastitis managed with traditional Chinese medicine: A case report.Medicine · 2026Article
- Clinical factors of prolonged treatment duration in patients with non-puerperal mastitis.Gland surgery · 2026Article
- Systemic corticosteroid bridging followed by ultrasound-guided microwave ablation for recurrent male plasma cell mastitis: a case report.Gland surgery · 2026Article
- Demographic characteristics and clinical analysis of patients with plasma cell mastitis: a single-center, retrospective, cross-sectional study.Gland surgery · 2026Article
- Plasma cell mastitis: a comprehensive review of etiological advances and future directions.Frontiers in immunology · 2026Review
- Logistic regression-based model for differential diagnosis between plasma cell mastitis and non-mass type breast cancer.Frontiers in oncology · 2026Article
- Prolactin-Linked Plasma Cell-Macrophage Immune Phenotype in Synchronous Bilateral Plasma Cell Mastitis: A Two-Center Prediction Study with Tissue Correspondence.International journal of women's health · 2026Article
- Recent Advances in Pathogenesis, Diagnosis and Integrated Traditional Chinese Medicine Therapy for Plasma Cell Mastitis.International journal of general medicine · 2026Review
- Postoperative breast function and quality of life follow-up study in patients with plasma cell mastitis: a 1-year longitudinal analysis.Frontiers in medicine · 2026Article
- Modified Nipple Correction Surgery Combined With Debridement for Refractory Nonpuerperal Mastitis: A Clinical Study.The breast journal · 2026Article
- Multimodal imaging pitfalls in differentiating unilateral plasma cell mastitis from breast cancer: a case description.Quantitative imaging in medicine and surgery · 2025Article
- Case Report: Experience in the diagnosis and treatment of a male patient with plasma cell mastitis in the lump stage and review of the literature.Frontiers in medicine · 2025Article
- Risk factor analysis and development of a nomogram prediction model for Plasma Cell Mastitis.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundPlasma cell mastitis (PCM), also termed mammary duct ectasia, is a chronic nonbacterial inflammatory disease characterized by mammary duct dilation and plasma cell infiltration. Due to its varied and nonspecific clinical presentation, PCM is frequently misdiagnosed as breast cancer, complicating clinical management.
objectivesThis review aims to summarize recent advances in the understanding of PCM, focusing on its etiology, clinical manifestations, diagnosis, and treatment strategies, as well as clarifying differential diagnostic points with granulomatous mastitis (GLM).
methodsWe reviewed recent literature highlighting clinical characteristics, diagnostic approaches, and therapeutic options related to PCM, including comparative studies addressing differences between PCM and GLM. DISCUSSION: Recent progress has enhanced understanding of PCM's clinical and pathological features, yet distinguishing PCM from GLM remains clinically challenging due to overlapping presentations. An integrated approach involving clinical evaluation, imaging modalities, and histopathological examination is recommended to improve diagnostic accuracy and clinical outcomes.
conclusionFurther investigation into the pathogenesis of PCM is essential for developing more precise diagnostic criteria and effective treatments, ultimately improving patient prognosis and reducing misdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.